The BreaD Study - Bio-availability of D2 Vitamin Present in Bread
NCT ID: NCT02525003
Last Updated: 2015-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2014-01-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Bioavailability of Vitamin D2 in Yeast and Bread
NCT02720575
Nursing-Home Residents Given Bread Fortified With Vitamin D3
NCT00789503
OASIS Study: Vitamin D Deficiency Prevention Among Older Adults in Ireland
NCT06705582
Assessment of the Efficacy of Vitamin D-fortified Bread in Healthy Adults
NCT02516254
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT01398202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: placebo
Group 1: daily dose of regular bread (87 g/d) and placebo pill (0 µg of vitamin D/d) for 8 weeks
No interventions assigned to this group
Group 2: Vitamin D2 supplement
Group 2: daily dose of regular bread (87 g/d) and D2 supplement (25 µg of vitamin D2/d.) for 8 weeks
Vitamin D2
Experimental group 2: daily vitamin D2 supplement 25ug/d for 8 weeks
Group 3: Vitamin D3 supplement
Group 3: daily dose of regular bread (87 g/d) and D3 supplement (25 µg of vitamin D3/d.) for 8 weeks
Vitamin D3
Experimental group 3: daily vitamin D3 supplement 25ug/d for 8 weeks
Group 4: Vitamin D2-fortified bread
Group 4: D2 fortified bread containing 25 µg of vitamin D2/d (bread dose 87g/d) and placebo pill for 8 weeks
Vitamin D2 fortified bread
Experimental group 4: vitamin D2 fortified bread containing 25 µg of vitamin D2/d (bread dose 87g/d) and placebo pill for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D2
Experimental group 2: daily vitamin D2 supplement 25ug/d for 8 weeks
Vitamin D3
Experimental group 3: daily vitamin D3 supplement 25ug/d for 8 weeks
Vitamin D2 fortified bread
Experimental group 4: vitamin D2 fortified bread containing 25 µg of vitamin D2/d (bread dose 87g/d) and placebo pill for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian origin,
* body mass index (BMI) \<30 kg/m2
* age 20-40 years
Exclusion Criteria
* a vacation in a sunny place during the study or within the preceding 2 months
* regular use of vitamin D supplements \>15 µg/d
* pregnancy or breastfeeding during the study
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Cork
OTHER
Technical University of Denmark
OTHER
University of Helsinki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christel Lamberg-Allardt
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christel Lamberg-Allardt
Role: STUDY_DIRECTOR
University of Helsinki
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Food and Environmental Sciences, University of Helsinki
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HelsinkiUni
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.